Shingles Vaccine
Shingrix became the second shingles vaccine to be licensed in the United States, becoming the preferred shingles vaccine in 2017.
Shingrix became the second shingles vaccine to be licensed in the United States, becoming the preferred shingles vaccine in 2017.